Two-year CSS rates for the cohort stratified according to subtype were 88% (95% CI 86–91), 66% (95% CI 46–78), and 97% (95% CI 76–99) for ccRCC, pRCC, and chRCC, respectively (p < 0.001). The gene discussed is PRCC; the disease is nonpapillary renal cell carcinoma.